造血负性调控因子与再生障碍性贫血发病机制的研究进展
被引量:5
摘要
再生障碍性贫血患者的骨髓和外周血中存在细胞因子水平的变化,其中重要的负性调控因子有肿瘤坏死因子-α、γ-干扰素、转化生长因子-β和一氧化氮等。现就这几种重要的负性调控因子与再障发病机制的研究进展作一综述。
出处
《国际输血及血液学杂志》
CAS
2007年第1期55-57,共3页
International Journal of Blood Transfusion and Hematology
基金
广东省自然科学基金项目(编号:5000138)
参考文献20
-
1Dufour C, Corcione A, Svahn J, et al. TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro. Blood, 2003, 102 (6): 2053-2059.
-
2Hara T, Ando K, Tsurumi H, et al. Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia. Eur J Haematol, 2004,73 (1):10-16.
-
3Verma A, Deb DK, Sassano A,et al. Cutting edge : activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia. J Immunol, 2002, 168 (12):5984-5988.
-
4Martinez-Jaramillo G, Flores-Figueroa E, Gomez-Morales E, et al. Tumor necrosis factor-alpha levels in long-term marrow cultures from patients with aplastic anemia: modulation by granulocyte-macrophage colony-stimulating factor. Am J Hematol, 2001, 68 (3):144-148.
-
5Dubey S, Shukla P, Nityanand S. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia. Ann Hematol, 2005,84 (9):572-577.
-
6Kast RE, Altschuler EL. Proposal for using small molecule tumor necrosis factor-alpha lowering agents, possibly bupropion, in aplastic anemia. Med Hypotheses, 2005, 65(2) : 374-376.
-
7Geissler K, Kabrna E, Kollars M, et al. Interleukin-10 inhibits in vitro hematopoietic suppression and production of interferon-gamma and tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with aplastic anemia. Hematol J, 2002,3(4) :206-213.
-
8Wenxin L,Jinxiang F,Yong W. Expression of membrane-bound IL-15 by bone marrow fibroblast-like stromal cells in aplastic anemia. Int Immunol 2005,17 (4) : 429-437.
-
9Welsh JP, Rutherford TR, Flynn J, et al. In vitro effects of interferon-gamma and tumor necrosis factor-alpha on CD34+ bone marrow progenitor cells from aplastic anemia patients and normal donors. HematolJ, 2004, 5(1):39-46.
-
10Zeng W, Miyazato A, Chen G, et al. Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. Blood, 2006, 107 (1): 167-175.
同被引文献54
-
1甘欣锦,蒋楠.浅议再生障碍性贫血的中医病因病机[J].国医论坛,2006,21(1):13-14. 被引量:1
-
2黄永兰,黄绍良.儿童再生障碍性贫血免疫介导发病机制及治疗进展[J].中华儿科杂志,2006,44(2):153-155. 被引量:13
-
3邵宗鸿,袁烨.再生障碍性贫血免疫发病机制及免疫治疗[J].中国实用内科杂志:临床前沿版,2006,26(2):252-255. 被引量:83
-
4郑邈,刘文励,孙汉英.再生障碍性贫血的诊断和治疗[J].中国医师进修杂志(内科版),2006,29(11):6-10. 被引量:3
-
5Young NS, Scheinberg P, Calado RT. Aplastic anemia [ J ]. Curr Opin Hematol,2008,15 (3) : 162 - 168.
-
6Briot D,Mace- Aime G, Subra F,et al. Aberrant activation of stress- response pathways leads to TNF - alpha oversecretion in Fanconi anemia [J]. Blood,2008,111 (4) :1913 - 1923.
-
7Gu Y, Hu Y, Liu C, et al. Interleukin (IL) - 17 promotes macrophages to produce IL - 8, IL - 6 and tumor necrosis factor - alpha in aplastic anemia [ J ]. Br J Haematol,2008,142 ( 1 ) : 109 - 114.
-
8Solomou EE ,Keyvanfar K,Young NS. T - beta Thl transcription factor, is up - regulated in T cells from patients with aplastic anemia [ J ]. Blood ,2006,107 (10) :3983 - 3991.
-
9Secchiero P, Zauli G. Tumor - necrosis - factor - related apoptosis - inducing ligand and the regulation of hematopoiesis[ J]. Curr Opin Hematol2008,15 ( 1 ) :42 - 48.
-
10Hara T, Audo K, Tsunmi H, et al. Excessive production of tumor necrosis factor - alpha by bone marrow T lymplaocytes is essential in causing bone marrow failure in patients with aplastic anemia [ J ]. Eur J Haematol, 2004,73( 1 ) :10 - 16.
引证文献5
-
1赵晓庆,马夫天,张宝玺,吴晓莉.再生障碍性贫血患儿骨髓细胞凋亡与肿瘤坏死因子-α和凋亡相关因子/凋亡相关因子配体系统的关系[J].实用儿科临床杂志,2009,24(15):1172-1174. 被引量:1
-
2赵红勉.中西医结合治疗再生障碍性贫血疗效观察[J].中国误诊学杂志,2010,10(9):2058-2059.
-
3方遒,张慧英.中西医结合治疗再生障碍性贫血的效果评价[J].中国基层医药,2010,17(18):2494-2495.
-
4王海丽,魏武.再生障碍性贫血中T-bet的表达及其对CD4^+ T细胞极化的调控[J].中国实验血液学杂志,2011,19(2):546-549. 被引量:3
-
5姜鑫,滕镕,孙淼,王丹,周张青,宋国齐.再生障碍性贫血患者血清对人骨髓间充质干细胞凋亡的影响[J].中华血液学杂志,2014,35(2):168-169. 被引量:3
二级引证文献7
-
1谢垒,盛光耀,徐学聚,王颖超,赵晓明.抗胸腺细胞球蛋白联合环孢素治疗重型再生障碍性贫血[J].实用儿科临床杂志,2011,26(9):701-702. 被引量:12
-
2YUE Lan-zhu SHAO Zong-hong.Research progress on the red cell diseases in China[J].Chinese Medical Journal,2012(15):2746-2751. 被引量:8
-
3陶林静.儿童再生障碍性贫血淋巴细胞亚群及其与血常规相关性的研究[J].中国实用医药,2014,9(35):39-40. 被引量:1
-
4马洪霞,陈蕾,董秀娟.改良非清髓造血干细胞移植治疗重型再生障碍性贫血的临床探讨[J].中国现代药物应用,2016,10(1):55-56.
-
5张哲,曾宪卓,鲁菲,陈帅,郭明辉,董慧君.人间充质干细胞的无异源培养体系研究进展[J].现代生物医学进展,2016,16(34):6793-6796. 被引量:1
-
6柯福彬,Anil Kumar Yadav,谢晓恬,乔晓红.再生障碍性贫血患儿骨髓T-bet、GATA3蛋白和外周血细胞因子表达及意义[J].同济大学学报(医学版),2021,42(1):80-84. 被引量:4
-
7赵亚军,孙兴卫.再生障碍性贫血患者T淋巴细胞亚群表达特点[J].热带医学杂志,2019,19(2):204-206. 被引量:8
-
1陈向东,陈洪,苏文婷,费烨,申洁,周曾同.Th17细胞在寻常型天疱疮发病中的作用[J].同济大学学报(医学版),2009,30(4):106-109. 被引量:6
-
2周乃慧,范卫新.转化生长因子-β在毛囊生物学中的研究进展[J].临床皮肤科杂志,2008,37(1):63-65. 被引量:2
-
3杨桂珍,杨萍.再生障碍性贫血患者血清IL-8、TNF-α水平的检测及其意义[J].中国基层医药,2008,15(2):198-199. 被引量:1
-
4刘增慧,肖扬,蒋祖军,李力,高扬,李勇华,李利,庞妍,欧阳玲,邝丽萍.骨髓间充质干细胞上调再生障碍性贫血患者CD4^+ CD25^+ Foxp3^+调节性T细胞的临床研究[J].实用医学杂志,2011,27(9):1582-1585. 被引量:7
-
5向芳,普雄明,靳颖.窄谱UVB治疗前后银屑病患者皮损中TGF-βs的表达[J].中国麻风皮肤病杂志,2009,25(5):350-352.
-
6单宁宁,姜玉杰,隋潇徽,李颖,刘新,许洪志,王欣.再生障碍性贫血患者血清中IL-18及IL-18BP的表达水平及其临床意义[J].中华血液学杂志,2011,32(11):783-785. 被引量:4
-
7孙芸,何威,张国威,何云志,黄海,郑红.寻常性银屑病皮损表皮中Smad7表达的检测及其临床意义[J].临床皮肤科杂志,2006,35(1):3-5. 被引量:5
-
8蔡艳梅,李洪涛,苗永飞,陈杰文,司炜弘,栗书贤,李艾芳,郭金光,张爱民.祛白消斑方对寻常型白癜风患者血清IL-17、IL-23及TGF-β水平的影响[J].临床合理用药杂志,2015,8(4):86-87. 被引量:4
-
9刘悦,赵玉铭.寻常性银屑病皮损表达转化生长因子-β的免疫组化研究[J].中国中西医结合皮肤性病学杂志,2008,7(2):90-92. 被引量:1
-
10李宏雨,武继红,胥艳红,杜洪涛,陈秋霞,梁梅.环孢菌素联合司坦唑醇治疗再生障碍性贫血48例疗效观察[J].吉林医学,2011,32(35):7475-7476. 被引量:3